ZEMA Pharma Consulting ApS — Credit Rating and Financial Key Figures

CVR number: 42680427
Hjemmevej 42, 2870 Dyssegård

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
Gross profit1 146.081 472.11130.75
Employee benefit expenses-44.48- 501.20- 519.96
EBIT1 101.61970.91- 389.21
Other financial income8.6971.92111.28
Other financial expenses-97.73-1.37-3.70
Pre-tax profit1 012.571 041.46- 281.63
Income taxes- 223.01- 229.11
Net earnings789.56812.35- 281.63

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total5.725.86
Long term receivables total
Inventories total
Current trade debtors20.49
Current other receivables12.91
Current deferred tax assets8.10
Short term receivables total41.50
Other current investments685.411 229.01521.28
Cash and bank deposits501.81351.8064.03
Cash and cash equivalents1 187.221 580.82585.31
Balance sheet total (assets)1 187.221 586.54632.67

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Shares repurchased789.00
Other reserves- 789.00
Retained earnings0.56812.91
Profit of the financial year789.56812.35- 281.63
Shareholders equity total829.56852.91571.29
Non-current liabilities total
Current trade creditors12.0012.0012.00
Short-term deferred tax liabilities221.10214.972.22
Other non-interest bearing current liabilities124.56506.6547.17
Current liabilities total357.67733.6261.39
Balance sheet total (liabilities)1 187.221 586.54632.67
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.